These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 682847

  • 1. [Comparative study of 2 drugs used in the treatment of cerebral vascular insufficiency: I-Eburnamonine and Vincamine].
    Linquette M.
    Lille Med; 1978 May; 23(5 Suppl 1):379-81. PubMed ID: 682847
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of treatment with Vincimax in 60 cases of cerebral circulatory insufficiency].
    Desruelles J, Camart JF.
    LARC Med; 1981 Dec; 1(3):86-90. PubMed ID: 7349693
    [No Abstract] [Full Text] [Related]

  • 3. [Double-blind study of the therapeutic activity of cerebroxine in the treatment of chronic cerebral circulatory insufficiency].
    Holemans P.
    Brux Med; 1979 May; 59(5):279-85. PubMed ID: 380784
    [No Abstract] [Full Text] [Related]

  • 4. [Multi-center clinical study of the effects of a vasoregulatory-eumetabolic drug (vincamine hydrochloride) on the psychological symptoms of cerebrovascular insufficiency].
    Periti P, Periti G, Colombo Pirola L.
    Clin Ter; 1981 Apr 30; 97(2):137-45. PubMed ID: 7016415
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L, Barbagallo G, Costanzo E, Sciacca A, Russo S.
    Clin Ter; 1981 Feb 28; 96(4):371-81. PubMed ID: 7214860
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical evaluation of (-) eburnamonine in chronic cerebrovascular insufficiency].
    De Pergola E, Di Lorenzo L, De Pergola G.
    G Clin Med; 1980 Aug 28; 61(8):628-42. PubMed ID: 7004986
    [No Abstract] [Full Text] [Related]

  • 7. [Vincamine in the treatment of cerebral circulatory insufficiency in old age].
    Turrisi E, D'Alise R, Mea A, Vitagliano A.
    Minerva Cardioangiol; 1975 Jan 28; 23(1):20-32. PubMed ID: 1143645
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
    Mikus P.
    Arzneimittelforschung; 1978 Jan 28; 28(11):2165-8. PubMed ID: 582924
    [Abstract] [Full Text] [Related]

  • 9. [Vincamine in the therapy of cerebral vascular diseases in the aged].
    De Candia O, Bartolucci E, Mancinella A, Baghiris D.
    Clin Ter; 1979 May 31; 89(4):373-80. PubMed ID: 535317
    [No Abstract] [Full Text] [Related]

  • 10. [Controlled clinical study of the effects of Anasclerol in hospitalized patients with cerebrovascular disorders].
    Riccardi T, Passeri F, Locatelli F.
    Minerva Med; 1978 Sep 15; 69(42):2873-8. PubMed ID: 358021
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ, Jocquet P, Jacquy J, Henriet M.
    Arzneimittelforschung; 1978 Sep 15; 28(9):1654-7. PubMed ID: 383107
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of initial cerebrovascular insufficiency with vincamine. Polycentric research on 828 cases].
    Minerva Med; 1978 Jun 23; 69(31):2095-113. PubMed ID: 351463
    [Abstract] [Full Text] [Related]

  • 13. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C, Ferrante P.
    Minerva Med; 1974 Apr 18; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract] [Full Text] [Related]

  • 14. [Drug therapy in cerebral disorders. A double-blind study with Cetal retard in aged subjects].
    Schenker H.
    Med Klin; 1979 Oct 24; Suppl():48-50. PubMed ID: 542168
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical, rheoencephalographic and ophthalmodynamographic double-blind studies of the effects of vincamine in the treatment of cerebrovascular diseases].
    Kauchtschischvili G, Nappi G, Bono G.
    Minerva Med; 1974 May 26; 65(40):2296-315. PubMed ID: 4608671
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical and Neuropsychological changes associated with vincamin treatment in cerebrovascular disease (author's transl)].
    Ambrozi L, Bruck J, Tschabitscher H.
    Nervenarzt; 1982 Mar 26; 53(3):141-3. PubMed ID: 7078689
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy of Cetal retard in cerebral insufficiency in general practice].
    Bartels H.
    Med Klin; 1979 Oct 24; Suppl():46-7. PubMed ID: 542167
    [No Abstract] [Full Text] [Related]

  • 18. [Therapeutic influence of vincamine on impairment of cerebral performance in elderly patients. Results of a double-blind study (author's transl)].
    Schenker H.
    Schweiz Rundsch Med Prax; 1979 Jul 31; 68(31):1005-11. PubMed ID: 379854
    [No Abstract] [Full Text] [Related]

  • 19. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acute phase of stroke.
    Thiery E, Otte G, Vander Eecken H.
    Arzneimittelforschung; 1979 Jul 31; 29(3):671-4. PubMed ID: 582751
    [Abstract] [Full Text] [Related]

  • 20. [Double-blind controlled study of the effects of vincamine hydrochloride on some parameters of cardiovascular function in aged bronchopneumopathic patients].
    Mazzola C, Della Torre F, Izzo M, Colombo Pirola L.
    Clin Ter; 1979 Dec 15; 91(5):485-503. PubMed ID: 397034
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.